Role of miR-143 targeting KRAS in colorectal tumorigenesis
- PMID: 19137007
- DOI: 10.1038/onc.2008.474
Role of miR-143 targeting KRAS in colorectal tumorigenesis
Abstract
Dysregulated expression of microRNAs (miRNAs) is associated with a variety of diseases, including colorectal cancer. By comparing more than 200 miRNAs in 13 pairs of matched colorectal cancer and normal adjacent tissue samples through qRT-PCR and microarray analysis, we found a widespread disruption of miRNA expression during colorectal tumorigenesis. In particular, among a panel of presumed targets generated by in silico analysis that may interact with these aberrantly expressed miRNAs, KRAS oncogene has been further experimentally validated as the target of miR-143. First, an inverse correlation between KRAS protein and miR-143 in vivo was found. Second, KRAS expression in Lovo cells was significantly abolished by treatment with miR-143 mimic, whereas miR-143 inhibitor increased KRAS protein level. Third, luciferase reporter assay confirmed that miR-143 directly recognize the 3'-untranslated region of KRAS transcripts. Four, Lovo cells treated with miR-143 inhibitor showed a stimulated cell proliferation, whereas miR-143 overexpression had an opposite effect. Finally, inhibition of KRAS expression by miR-143 inhibits constitutive phosphorylation of ERK1/2. Taken together, the present study provides the first evidences that miR-143 is significant in suppressing colorectal cancer cell growth through inhibition of KRAS translation.
Similar articles
-
The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.Carcinogenesis. 2010 Oct;31(10):1726-33. doi: 10.1093/carcin/bgq160. Epub 2010 Jul 30. Carcinogenesis. 2010. PMID: 20675343
-
MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.Br J Cancer. 2015 Apr 28;112(9):1480-90. doi: 10.1038/bjc.2015.125. Br J Cancer. 2015. PMID: 25919696 Free PMC article.
-
MicroRNA profiling differentiates colorectal cancer according to KRAS status.Genes Chromosomes Cancer. 2012 Jan;51(1):1-9. doi: 10.1002/gcc.20925. Epub 2011 Sep 15. Genes Chromosomes Cancer. 2012. PMID: 21922590
-
MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).J Biol Chem. 2013 Mar 29;288(13):9508-18. doi: 10.1074/jbc.M112.367763. Epub 2013 Jan 15. J Biol Chem. 2013. PMID: 23322774 Free PMC article.
-
KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.Anticancer Res. 2012 Jun;32(6):2271-5. Anticancer Res. 2012. PMID: 22641662
Cited by
-
Study of KRAS-Related miRNA Expression in Colorectal Cancer.Cancer Manag Res. 2022 Oct 17;14:2987-3008. doi: 10.2147/CMAR.S368551. eCollection 2022. Cancer Manag Res. 2022. PMID: 36262749 Free PMC article.
-
MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6.Protein Cell. 2016 Jun;7(6):434-44. doi: 10.1007/s13238-016-0277-2. Epub 2016 May 26. Protein Cell. 2016. PMID: 27230400 Free PMC article.
-
The influence of sex hormones on renal cell carcinoma.Ther Adv Med Oncol. 2024 Aug 21;16:17588359241269664. doi: 10.1177/17588359241269664. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39175990 Free PMC article. Review.
-
MicroRNAs in the pathobiology of sarcomas.Lab Invest. 2015 Sep;95(9):987-94. doi: 10.1038/labinvest.2015.81. Epub 2015 Jun 29. Lab Invest. 2015. PMID: 26121318 Review.
-
MicroRNAs in pancreatic cancer metabolism.Nat Rev Gastroenterol Hepatol. 2012 Apr 17;9(6):334-44. doi: 10.1038/nrgastro.2012.63. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22508159 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous